Skip to search boxSkip to navigationSkip to main content

Transverse myelitis associated with autoimmune polyglandular syndrome type 3B: A case report in Peru

Original title: Transverse myelitis associated with autoimmune polyglandular syndrome type 3B: A case report in Peru
  • Miguel A. Vences(corresponding author)
    ,
  • Milene Morocho-Pinedo
    ,
  • Rossy J. Oliveros-Ramirez
    ,
  • Lizset C. Ballena-Cupe
    ,
  • Julio C. Alvarez-Márquez
    ,
  • Mirla Villafuerte-Espinoza
*Corresponding author for this work
  • Hospital Nacional Edgardo Rebagliati Martins, EsSalud
    ,
  • Universidad Científica del Sur
    ,
  • Universidad Peruana de Ciencias Aplicadas
    ,
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 216-220 (5 pages)

Journal (Volume, Issue Number)

Neurologia Argentina (Volume 15, Issue 3)

Publication milestones

  • Accepted/In press - 2023
  • Published - 01/07/2023

Publication status

Published - 01/07/2023

ISSN

1853-0028

Publication IDs

  • Scopus: 85150359862

Abstract

Autoimmune polyglandular syndrome is a rare disease with a low incidence worldwide. We present the case of an adult male with a history of parietal antibody-positive gastritis, central retinal vein obstruction and transverse myelitis. The patient was admitted for exacerbation of myelitis symptoms. The thyroid profile was positive for antibodies, indicating the presence of euthyroid autoimmune thyroid disease. The patient was finally diagnosed with autoimmune polyglandular syndrome type 3B. In the absence of adequate response to methylprednisolone and immunoglobulin, we started treatment with cyclophosphamide and later maintenance therapy with azathioprine. At one year of follow-up, the patient presented paraparesis as sequel, did not present new relapses and control tests were negative for another associated disease.

Funding Details

We thank the Universidad Científica del Sur for the English editing support.
FundersFunding numbersUCSUR: UCS-